Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
出版年份 2021 全文链接
标题
Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of Success
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-07
DOI
10.3389/fmicb.2021.750124
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Skin tests for the detection of Mycobacterial infections: achievements, current perspectives, and implications for other diseases
- (2021) Malcolm S. Duthie et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
- (2021) Willemijn F. Rijnink et al. Frontiers in Immunology
- Emerging concepts in the science of vaccine adjuvants
- (2021) Bali Pulendran et al. NATURE REVIEWS DRUG DISCOVERY
- The success of SARS-CoV-2 vaccines and challenges ahead
- (2021) Kanta Subbarao Cell Host & Microbe
- The impact of COVID-19 on TB: a review of the data
- (2021) C. F. McQuaid et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- 100 years of Mycobacterium bovis bacille Calmette-Guérin
- (2021) Christoph Lange et al. LANCET INFECTIOUS DISEASES
- MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG
- (2021) Carlos Martín et al. VACCINE
- Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
- (2020) Stefan H. E. Kaufmann Frontiers in Immunology
- Towards new TB vaccines
- (2020) Benedict Brazier et al. Seminars in Immunopathology
- Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host’s Response to Pathogens
- (2019) Mihai G. Netea et al. Cell Host & Microbe
- Designing tuberculosis vaccine efficacy trials – lessons from recent studies
- (2019) Ann M. Ginsberg Expert Review of Vaccines
- Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality
- (2019) Stefan H.E. Kaufmann Human Vaccines & Immunotherapeutics
- Immunology's Coming of Age
- (2019) Stefan H. E. Kaufmann Frontiers in Immunology
- Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2019) Dereck R. Tait et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stopping live vaccines after disease eradication may increase mortality
- (2019) Peter Aaby et al. VACCINE
- The Listeriolysin O PEST-like Sequence Co-opts AP-2-Mediated Endocytosis to Prevent Plasma Membrane Damage during Listeria Infection
- (2018) Chen Chen et al. Cell Host & Microbe
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Listeriolysin O: A phagosome-specific cytolysin revisited
- (2018) Brittney N. Nguyen et al. CELLULAR MICROBIOLOGY
- Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial
- (2017) Surendra K. Sharma et al. Scientific Reports
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and γδ Cells in Tuberculosis Infection and Disease
- (2017) Felicity Coulter et al. Frontiers in Immunology
- TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development
- (2017) Stefan H. E. Kaufmann et al. Frontiers in Immunology
- Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
- (2016) André G. Loxton et al. Clinical and Vaccine Immunology
- Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG Δ ureC :: hly Improves Protection against Tuberculosis
- (2016) Martin Gengenbacher et al. mBio
- The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
- (2016) Rein M. G. J. Houben et al. PLOS MEDICINE
- Tuberculosis
- (2016) Madhukar Pai et al. Nature Reviews Disease Primers
- Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1
- (2015) Ruth Wassermann et al. Cell Host & Microbe
- Tuberculosis vaccines: Time for a global strategy
- (2015) Stefan H. E. Kaufmann et al. Science Translational Medicine
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
- (2015) E. Stylianou et al. VACCINE
- “Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare: FIG 1
- (2015) David C. Alexander et al. mBio
- Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
- (2015) François Spertini et al. Lancet Respiratory Medicine
- Central Memory CD4+ T Cells Are Responsible for the Recombinant Bacillus Calmette-Guérin ΔureC::hly Vaccine's Superior Protection Against Tuberculosis
- (2014) Alexis Vogelzang et al. JOURNAL OF INFECTIOUS DISEASES
- The Recombinant BCG ΔureC::hlyVaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation
- (2014) Hiroyuki Saiga et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis
- (2014) A. Roy et al. BMJ-British Medical Journal
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
- (2013) F. Smaill et al. Science Translational Medicine
- Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
- (2013) Leander Grode et al. VACCINE
- The recombinant tuberculosis vaccine rBCG ΔureC::hly+ induces apoptotic vesicles for improved priming of CD4+ and CD8+ T cells
- (2012) Maura Farinacci et al. VACCINE
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
- (2012) Tom H. M. Ottenhoff et al. PLoS Pathogens
- BCG Vaccination Induces Different Cytokine Profiles Following Infant BCG Vaccination in the UK and Malawi
- (2011) Maeve K. Lalor et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
- (2011) Christiane Desel et al. JOURNAL OF INFECTIOUS DISEASES
- The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
- (2011) Alice Zwerling et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now